Analytical validation of a 12-gene molecular test for the prediction of distant recurrence in breast cancer.

Warf, M Bryan; Rajamani, Saradha; Krappmann, Kristin; Doedt, Jennifer; Cassiano, Jared; Brown, Krystal; Reid, Julia E; Kronenwett, Ralf; Roa, Benjamin B

Warf, M Bryan; Rajamani, Saradha; Krappmann, Kristin; Doedt, Jennifer; Cassiano, Jared; Brown, Krystal; Reid, Julia E; Kronenwett, Ralf; Roa, Benjamin B.

Afiliación

Warf MB; Myriad Genetic Laboratories, Inc., Salt Lake City, UT 84108, USA.
Rajamani S; Myriad Genetic Laboratories, Inc., Salt Lake City, UT 84108, USA.
Krappmann K; Myriad Genetics, Inc., Salt Lake City, UT 84108, USA.
Doedt J; Myriad Genetics, Inc., Salt Lake City, UT 84108, USA.
Cassiano J; Sividon Diagnostics GmbH, Cologne, Germany.
Brown K; Sividon Diagnostics GmbH, Cologne, Germany.
Reid JE; Sividon Diagnostics GmbH, Cologne, Germany.
Kronenwett R; Sividon Diagnostics GmbH, Cologne, Germany.
Roa BB; Myriad Genetic Laboratories, Inc., Salt Lake City, UT 84108, USA.

Future Sci OA ; 3(3): FSO221, 2017 Aug.

Article en En | MEDLINE | ID: mdl-28884016

Palabras clave

ER+/HER- invasive breast cancer; analytical validation; gene expression

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Future Sci OA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google